tirzepatide for weight loss approval is FDA-approved management, with clinical trials showing average weight of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting Tirzepatide approved for weight loss

Patient Assistance Program - Available Products

This medicine is usually prescribed in combination with other diabetes medications

If the total is significantly more or less, recalculate your concentration accordingly

Compare week 12 with the week-0 baseline and week 6

While they are highly effective, they are not without digestive consequences, such as nausea, vomiting, or delayed gastric emptying

The most supportive approach is to follow the person's lead on whether they want to discuss their weight loss, avoid unsolicited comments about physical appearance, show interest in how they are feeling rather than how they look, and respond to expressions of anxiety about regain or body change with validation rather than reassurance-seeking behaviour